ACIU Shariah Compliance
Screening Methodology: AAOIFI
UNLOCK FOR FREE
Last Updated: December 02, 2025
Report Source: 2025 3rd Quarter Report
AC Immune SA. Stock Analysis ACIU
United States Health Care Micro Cap Report: AC Immune SA is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutic and diagnostic products for neurodegenerative diseases. The company is headquartered in Lausanne, Vaud and currently employs 133 full-time employees. The company went IPO on 2016-09-23. The firm focuses on precision medicine for neurodegenerative diseases. The company designs, discovers and develops therapeutic, as well as diagnostic products for prevention, diagnosis and treatment of diseases caused by misfolding proteins. Its SupraAntigen and Morphomer technology platforms to create antibodies, small molecules and vaccines designed to address a broad range of neurodegenerative indications, such as Alzheimer's disease (AD). The firm's pipeline includes nine therapeutic product candidates with five in clinical trials, and three diagnostic candidates. Its lead product candidate is Crenezumab, a humanized and monoclonal anti-Abeta antibody for Alzheimer’s disease. The company has collaborations with pharmaceutical companies, including Roche/Genentech, Eli Lilly, Biogen, Janssen Pharmaceuticals, Nestle Institute of Health Sciences, Life Molecular Imaging (formerly Piramal Imaging) and Essex Bio-Technology.
Read More AC Immune SA (ACIU) Chart
Key Statistics of AC Immune SA (ACIU)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$2.85Volume
260.56KP/E Ratio (TTM)
-52 Week Range
Market Cap
315.63MAvg. Volume
266.01KDividend Yield
-Financial Metrics & Statements of AC Immune SA (ACIU)
FAQ's for AC Immune SA (ACIU)
- According to Musaffa’s Shariah screening methodology, AC Immune SA (ACIU) is currently classified as NOT HALAL as of December 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.
Alternate Halal Stocks for AC Immune SA (ACIU)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
